Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis
Clinical trial NCT02748512 · COMPLETED
Trial details
- NCT number
- NCT02748512
- Sponsor
- EyePoint Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-23
- Primary completion
- 2017-08-17
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.